10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2015 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 9, 2016) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net revenues | $ 153,290 | 139,367 | 126,761 |
| Cost of revenues | 126,762 | 114,000 | 102,978 |
| Gross profit | 26,528 | 25,367 | 23,783 |
| Operating expenses | 17,074 | 16,568 | 15,746 |
| Operating profit | 9,454 | 8,799 | 8,037 |
| Interest expense, net | 838 | 600 | 509 |
| Loss on early extinguishment of debt | 0 | 521 | 0 |
| Income before income tax provision | 8,616 | 7,678 | 7,528 |
| Income tax provision | 3,386 | 3,033 | 2,928 |
| Income from continuing operations | 5,230 | 4,645 | 4,600 |
| Income (loss) from discontinued operations, net of tax | 9 | (1) | (8) |
| Net income | 5,239 | 4,644 | 4,592 |
| Net income attributable to noncontrolling interest | (2) | 0 | 0 |
| Net income attributable to CVS Health | 5,237 | 4,644 | 4,592 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 4.65 | 3.98 | 3.78 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | 0.01 | 0.00 | (0.01) |
| Net income attributable to CVS Caremark (in dollars per share) | 4.66 | 3.98 | 3.77 |
| Weighted average common shares outstanding (in shares) | 1,118 | 1,161 | 1,217 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 4.62 | 3.96 | 3.75 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | 0.01 | 0.00 | (0.01) |
| Net income attributable to CVS Caremark (in dollars per share) | 4.63 | 3.96 | 3.74 |
| Weighted average common shares outstanding (in shares) | 1,126 | 1,169 | 1,226 |
| Dividends declared per common share (in dollars per share) | 1.40 | 1.10 | 0.90 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2015 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 9, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net income | $ 5,239 | 4,644 | 4,592 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustments, net of tax | (100) | (35) | (30) |
| Net cash flow hedges, net of tax | 2 | 4 | 3 |
| Pension and other postretirement benefits, net of tax | (43) | (37) | 59 |
| Net other comprehensive income (loss) | (141) | (68) | 32 |
| Comprehensive income | 5,098 | 4,576 | 4,624 |
| Comprehensive income attributable to noncontrolling interest | (2) | 0 | 0 |
| Comprehensive income attributable to CVS Health | 5,096 | 4,576 | 4,624 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 9, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 148,954 | 132,406 | 114,993 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (122,498) | (105,362) | (91,178) |
| Cash paid to other suppliers and employees | (14,162) | (15,344) | (14,295) |
| Interest received | 21 | 15 | 8 |
| Interest paid | (629) | (647) | (534) |
| Income taxes paid | (3,274) | (2,931) | (3,211) |
| Net cash provided by operating activities | 8,412 | 8,137 | 5,783 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,367) | (2,136) | (1,984) |
| Proceeds from sale-leaseback transactions | 411 | 515 | 600 |
| Proceeds from sale of property and equipment and other assets | 35 | 11 | 54 |
| Acquisitions (net of cash acquired) and other investments | (11,475) | (2,439) | (415) |
| Purchase of available-for-sale investments | (267) | (157) | (226) |
| Maturity of available-for-sale investments | 243 | 161 | 136 |
| Net cash used in investing activities | (13,420) | (4,045) | (1,835) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (685) | 685 | (690) |
| Proceeds from issuance of long-term debt | 14,805 | 1,483 | 3,964 |
| Repayments of long-term debt | (2,902) | (3,100) | 0 |
| Payment of contingent consideration | (58) | 0 | 0 |
| Dividends paid | (1,576) | (1,288) | (1,097) |
| Proceeds from exercise of stock options | 299 | 421 | 500 |
| Excess tax benefits from stock-based compensation | 127 | 106 | 62 |
| Repurchase of common stock | (5,001) | (4,001) | (3,976) |
| Other | (3) | 0 | 0 |
| Net cash provided by (used in) financing activities | 5,006 | (5,694) | (1,237) |
| Effect of exchange rate changes on cash and cash equivalents | (20) | (6) | 3 |
| Net increase (decrease) in cash and cash equivalents | (22) | (1,608) | 2,714 |
| Cash and cash equivalents at the beginning of the year | 2,481 | 4,089 | |
| Cash and cash equivalents at the end of the year | 2,459 | 2,481 | 4,089 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 5,239 | 4,644 | 4,592 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,092 | 1,931 | 1,870 |
| Stock-based compensation | 230 | 165 | 141 |
| Loss on early extinguishment of debt | 0 | 521 | 0 |
| Deferred income taxes and other noncash items | (266) | (58) | (86) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (1,594) | (737) | (2,210) |
| Inventories | (1,141) | (770) | 12 |
| Other current assets | 355 | (383) | 105 |
| Other assets | 2 | 9 | (135) |
| Accounts payable and claims and discounts payable | 2,834 | 1,742 | 1,024 |
| Accrued expenses | 765 | 1,060 | 471 |
| Other long-term liabilities | (104) | 13 | (1) |
| Net cash provided by operating activities | 8,412 | 8,137 | 5,783 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2015 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 9, 2016) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| Assets: | ||
| Cash and cash equivalents | $ 2,459 | 2,481 |
| Short-term investments | 88 | 34 |
| Accounts receivable, net | 11,888 | 9,687 |
| Inventories | 14,001 | 11,930 |
| Deferred income taxes | 1,220 | 985 |
| Other current assets | 722 | 866 |
| Total current assets | 30,378 | 25,983 |
| Property and equipment, net | 9,855 | 8,843 |
| Goodwill | 38,106 | 28,142 |
| Intangible assets, net | 13,878 | 9,774 |
| Other assets | 1,440 | 1,445 |
| Total assets | 93,657 | 74,187 |
| Liabilities: | ||
| Accounts payable | 7,490 | 6,547 |
| Claims and discounts payable | 7,653 | 5,404 |
| Accrued expenses | 6,829 | 5,816 |
| Short-term debt | 0 | 685 |
| Current portion of long-term debt | 1,197 | 575 |
| Total current liabilities | 23,169 | 19,027 |
| Long-term debt | 26,267 | 11,630 |
| Deferred income taxes | 5,437 | 4,036 |
| Other long-term liabilities | 1,542 | 1,531 |
| Commitments and contingencies | 0 | 0 |
| Redeemable noncontrolling interest | 39 | 0 |
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | |
| Common stock, par value $0.01: 3,200 shares authorized, 1,699 shares issued and 1,101 shares outstanding at December 31, 2015 and 1,691 shares issued and 1,140 shares outstanding at December 31, 2014 | 17 | 17 |
| Treasury stock, at cost: 597 shares at December 31, 2015 and 550 shares at December 31, 2014 | (28,886) | (24,078) |
| Shares held in trust: 1 share at December 31, 2015 and 2014 | (31) | (31) |
| Capital surplus | 30,948 | 30,418 |
| Retained earnings | 35,506 | 31,849 |
| Accumulated other comprehensive income (loss) | (358) | (217) |
| Total CVS Health shareholders equity | 37,196 | 37,958 |
| Noncontrolling interest | 7 | 5 |
| Total shareholders equity | 37,203 | 37,963 |
| Total liabilities and shareholders equity | 93,657 | 74,187 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |